Metagenomi, Inc. (MGX)
NASDAQ: MGX · IEX Real-Time Price · USD
4.230
-0.190 (-4.30%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Metagenomi Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current202320222021
Market Capitalization
158---
Enterprise Value
-126-228-350-63
PS Ratio
3.35---
PB Ratio
0.57---
EV/Sales Ratio
--5.10-20.33-260.60
EV/EBITDA Ratio
-4.409.223.20
EV/EBIT Ratio
-3.798.543.00
EV/FCF Ratio
-2.25-22.20-2.97
Debt / Equity Ratio
0.17-0.36-0.25-1.50
Debt / EBITDA Ratio
--0.93-0.49-2.47
Debt / FCF Ratio
--0.481.182.29
Quick Ratio
4.734.057.594.46
Current Ratio
4.754.047.564.33
Asset Turnover
-0.120.06-
Interest Coverage
---417.61-70.00
Return on Equity (ROE)
-65.00%81.50%-
Return on Assets (ROA)
--17.50%-15.70%-
Return on Capital (ROIC)
-89.85%79.92%-146.16%
Earnings Yield
-48.76%---
Buyback Yield / Dilution
-521.79%-0.15%-4.34%-
Total Shareholder Return
-521.79%-0.15%-4.34%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).